Developer docs
API playgroundTry for free, no card

Search company profiles

Joswe Medical

Full company profile

uuid0026tlx

Namestring
Joswe Medical
Legal namestring
Jordanian Sweden Company for Medical Products and Sterilization
Websiteurl
joswe.com
Company typeenum
Private
Founded yearint
1996
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersAmman, Jordan
HQ citystring
Amman
HQ countrystring
Jordan
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals manufacturing, branded first generic medicines, cardiovascular pharmaceutical products, anti-infective medication manufacturing, MENA pharmaceutical manufacturer
Industry2 codes
1Small-Molecule Generics (Branded/Unbranded)
CodeHLAIABAAPrimaryYes
2Oral Solid Dose (OSD) Generics
CodeHLAIABADPrimaryNo
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals Manufacturing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Joswe Medical generates revenue through the manufacture and sale of branded first generic pharmaceutical products. The company develops and introduces new medications annually, focusing on high-priority pharmaceutical treatments. Products are sold through pharmacy distribution networks and healthcare providers across domestic and export markets.

joswe.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1PANDA
Description

Paracetamol-based pain relief and cold/flu medication brand including Panda 500, Panda Strong, Panda Advance, Panda Extra, Panda Night, Panda Syrup, Panda H, Panda Six Plus, and Panda Effervescent variants.

joswe.com
Core offering1 text field

Joswe Medical manufactures and sells branded first generic pharmaceutical products across 14 therapeutic categories including cardiovascular, CNS, anti-infective, respiratory, gastrointestinal, anti-histamine, inflammatory, musculoskeletal, endocrine, nutrition, men's health, disinfectant, and PANDA (analgesic) products. The company operates a manufacturing facility in Amman, Jordan, producing over 200 drug items for distribution through pharmacy networks and healthcare providers domestically and in over 20 international markets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Products reach patients in over 20 countries worldwide
+2 more records
Product and service1 record
1Cardiovascular Pharmaceutical Product Line
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

JFDA is the regulatory body overseeing pharmaceutical manufacturing in Jordan. The agency conducts regular field visits to monitor local manufacturing processes, assesses industry needs and suggestions, and provides technical support including priority registration for locally manufactured drugs. JFDA Director General Dr. Nizar Mahmoud Hmaidat visited the company headquarters and praised Joswe as a distinguished national pharmaceutical manufacturer. JFDA is working to support the pharmaceutical industry through simplified procedures, export boosting initiatives, and regulatory frameworks that ensure quality and drug security.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Egyptian pharmaceutical manufacturer with a broad branded-generic and specialty portfolio exported across MENA and Africa. Comparable therapeutic breadth and emerging-market go-to-market, though headquartered in a different jurisdiction.

TypeDirect peer
Description

UAE-based manufacturer of branded generics across cardiovascular, CNS, anti-infective, and other categories, exporting across the MENA region. Comparable peer in size, therapeutic mix, and export-led regional distribution model.

TypeBroad incumbent
Description

India-based global generic pharmaceutical manufacturer with a large small-molecule portfolio spanning cardiovascular, CNS, anti-infective, and other categories. Comparable generic molecule mix and emerging-market distribution, though at much greater scale.

TypeDirect peer
Description

Jordan-headquartered global pharmaceutical manufacturer with a comparable branded-generic and injectable portfolio across MENA, Europe, and the US. Most directly comparable MENA peer given shared Jordanian origin, regulatory familiarity, and overlapping therapeutic categories.

TypeDirect peer
Description

Jordanian pharmaceutical manufacturer of branded generics across multiple therapeutic categories. Directly comparable domestic peer with similar export footprint across MENA and overlapping product types (cardiovascular, anti-infective, CNS).

TypeRegional player
Description

One of Egypt's largest pharmaceutical manufacturers, producing branded generics across a wide therapeutic spectrum with strong MENA and African export presence. Comparable scale, portfolio breadth, and emerging-market generic orientation, though Egypt-led.

TypeRegional player
Description

Saudi-headquartered pharmaceutical company manufacturing branded generics and specialty products across cardiovascular, CNS, anti-infective, and other categories. Comparable MENA focus and product mix, primarily serving the GCC and wider Arab region.

TypeDirect peer
Description

Amman-based pharmaceutical manufacturer focused on branded generics in MENA therapeutic categories including cardiovascular, CNS, and anti-infective. Direct Jordanian peer with similar size, distribution model, and export orientation.

TypeRegional player
Description

Saudi Arabian pharmaceutical manufacturer producing branded generics and licensed products across multiple therapeutic categories, with regional and select international export. Comparable MENA branded-generic model.

TypeBroad incumbent
Description

India-headquartered global pharmaceutical manufacturer with deep branded-generic portfolio across respiratory, cardiovascular, anti-infective, and CNS, and a strong emerging-market and MENA presence. Comparable product categories and distribution approach, but at materially larger scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Joswe Medical

Generic Pharmaceuticals Manufacturingjoswe.com

Joswe Medical firmographics

Firmographics
Name
Joswe Medical
Legal name
Jordanian Sweden Company for Medical Products and Sterilization
Website
https://joswe.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Joswe Medical industry classification

Industry
Product category
Generic Pharmaceuticals Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
akta.pro secondary industry
Oral Solid Dose (OSD) Generics (HLAIABAD)

Keywords

  • Generic pharmaceuticals manufacturing
  • Branded first generic medicines
  • Cardiovascular pharmaceutical products
  • Anti-infective medication manufacturing
  • MENA pharmaceutical manufacturer

Where Joswe Medical is headquartered

Location

Headquarters

HQ city
Amman
HQ country
Jordan
HQ region
Middle East

Offices2 records

Markets served

Joswe Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Joswe Medical generates revenue through the manufacture and sale of branded first generic pharmaceutical products. The company develops and introduces new medications annually, focusing on high-priority pharmaceutical treatments. Products are sold through pharmacy distribution networks and healthcare providers across domestic and export markets.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Joswe Medical product offering

Product offering

Core offering

Joswe Medical manufactures and sells branded first generic pharmaceutical products across 14 therapeutic categories including cardiovascular, CNS, anti-infective, respiratory, gastrointestinal, anti-histamine, inflammatory, musculoskeletal, endocrine, nutrition, men's health, disinfectant, and PANDA (analgesic) products. The company operates a manufacturing facility in Amman, Jordan, producing over 200 drug items for distribution through pharmacy networks and healthcare providers domestically and in over 20 international markets.

Differentiator

Problem solved

Functional benefit

Brands

  • PANDA: Paracetamol-based pain relief and cold/flu medication brand including Panda 500, Panda Strong, Panda Advance, Panda Extra, Panda Night, Panda Syrup, Panda H, Panda Six Plus, and Panda Effervescent variants.

Products and services

  • Cardiovascular Pharmaceutical Product Line

Quantifiable outcome

  • Products reach patients in over 20 countries worldwide
  • +2 more outcomes

Companies that use Joswe Medical

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Joswe Medical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Joswe Medical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Jordan Food and Drug Administration (JFDA)coreOthersJFDA is the regulatory body overseeing pharmaceutical manufacturing in Jordan. The agency conducts regular field visits to monitor local manufacturing processes, assesses industry needs and suggestions, and provides technical support including priority registration for locally manufactured drugs. JFDA Director General Dr. Nizar Mahmoud Hmaidat visited the company headquarters and praised Joswe as a distinguished national pharmaceutical manufacturer. JFDA is working to support the pharmaceutical industry through simplified procedures, export boosting initiatives, and regulatory frameworks that ensure quality and drug security.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Joswe Medical competitors and assessment

Company assessment

Regional players

  • Eva Pharma: Egyptian pharmaceutical manufacturer with a broad branded-generic and specialty portfolio exported across MENA and Africa. Comparable therapeutic breadth and emerging-market go-to-market, though headquartered in a different jurisdiction.
  • EIPICO: One of Egypt's largest pharmaceutical manufacturers, producing branded generics across a wide therapeutic spectrum with strong MENA and African export presence. Comparable scale, portfolio breadth, and emerging-market generic orientation, though Egypt-led.
  • Tabuk Pharmaceuticals: Saudi-headquartered pharmaceutical company manufacturing branded generics and specialty products across cardiovascular, CNS, anti-infective, and other categories. Comparable MENA focus and product mix, primarily serving the GCC and wider Arab region.
  • SPIMACO Addwaeih: Saudi Arabian pharmaceutical manufacturer producing branded generics and licensed products across multiple therapeutic categories, with regional and select international export. Comparable MENA branded-generic model.

Direct peers

  • Julphar (Gulf Pharmaceutical Industries): UAE-based manufacturer of branded generics across cardiovascular, CNS, anti-infective, and other categories, exporting across the MENA region. Comparable peer in size, therapeutic mix, and export-led regional distribution model.
  • Hikma Pharmaceuticals: Jordan-headquartered global pharmaceutical manufacturer with a comparable branded-generic and injectable portfolio across MENA, Europe, and the US. Most directly comparable MENA peer given shared Jordanian origin, regulatory familiarity, and overlapping therapeutic categories.
  • Dar Al Dawa: Jordanian pharmaceutical manufacturer of branded generics across multiple therapeutic categories. Directly comparable domestic peer with similar export footprint across MENA and overlapping product types (cardiovascular, anti-infective, CNS).
  • Pharma International (PHI): Amman-based pharmaceutical manufacturer focused on branded generics in MENA therapeutic categories including cardiovascular, CNS, and anti-infective. Direct Jordanian peer with similar size, distribution model, and export orientation.

Broad incumbents

  • Aurobindo Pharma: India-based global generic pharmaceutical manufacturer with a large small-molecule portfolio spanning cardiovascular, CNS, anti-infective, and other categories. Comparable generic molecule mix and emerging-market distribution, though at much greater scale.
  • Cipla: India-headquartered global pharmaceutical manufacturer with deep branded-generic portfolio across respiratory, cardiovascular, anti-infective, and CNS, and a strong emerging-market and MENA presence. Comparable product categories and distribution approach, but at materially larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Joswe Medical social profiles

Digital presence

Joswe Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Joswe Medical leadership team

Management profile

Number of profiles

Profiles13 records

Joswe Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Joswe Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Joswe Medical

What does Joswe Medical do?

Joswe Medical manufactures and sells branded first generic pharmaceutical products across 14 therapeutic categories including cardiovascular, CNS, anti-infective, respiratory, gastrointestinal, anti-histamine, inflammatory, musculoskeletal, endocrine, nutrition, men's health, disinfectant, and PANDA (analgesic) products. The company operates a manufacturing facility in Amman, Jordan, producing over 200 drug items for distribution through pharmacy networks and healthcare providers domestically and in over 20 international markets.

Is Joswe Medical a public or private company?

Joswe Medical is a private company. It is classified as family owned and is currently operating.

When was Joswe Medical founded?

Joswe Medical was founded in 1996. It employs 1,001 to 5,000 people.

Where is Joswe Medical based?

Joswe Medical is headquartered in Amman, Jordan, in the Middle East region.

How does Joswe Medical make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Joswe Medical's main competitors?

Regional players on record are Eva Pharma, EIPICO, Tabuk Pharmaceuticals and SPIMACO Addwaeih. Direct peers are Julphar (Gulf Pharmaceutical Industries), Hikma Pharmaceuticals, Dar Al Dawa and Pharma International (PHI). Broad incumbents are Aurobindo Pharma and Cipla.

Does Joswe Medical have an API?

No public API is recorded for Joswe Medical.

What industry is Joswe Medical in?

Joswe Medical's product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIABAD, Oral Solid Dose (OSD) Generics. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales